NCT00268723View on ClinicalTrials.gov

Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB

PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
Exercise-induced Bronchospasm
Interventions
DRUG

Levalbuterol tartrate HFA MDI

levalbuterol MDI 90 mcg QID

DRUG

Placebo

Placebo MDI QID

Trial Locations (2)

Unknown

Denver

Burke

All Listed Sponsors
lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT00268723 - Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB | Biotech Hunter | Biotech Hunter